We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This page contains an overview of the Psychoactive Substances Act and supporting documents.
Guidance for substance misuse commissioners on tackling new psychoactive substance (NPS) use, often called ‘legal highs.’
This guidance is to help researchers comply with the Psychoactive Substances Act, which comes into effect on 26 May 2016.
These documents are part of the Psychoactive Substances Bill.
The Government Chemist team has published guidance on analytical limits for controlled cannabinoids in specified products containing cannabidiol (CBD)
Toolkit to support staff to deal with new psychoactive substances (NPS) use, often called ‘legal highs, in prison and secure settings.
This report is concerned with advice on the issue of novel psychoactive substances (NPS), sometimes known as ‘legal highs’.
A resource pack on new psychoactive substances for educators and practitioners working with young people.
Recommendations for a temporary class drug order on a number of methylphenidate-based novel psychoactive substances.
This guidance is to help retailers understand the Psychoactive Substances Act 2016, which comes into effect on 26 May 2016.
This review sought to measure changes in outcomes before and after the implementation of the Act, to provide an indication of whether its aims are being achieved.
Licence and registration application information for companies that deal in precursor chemicals.
Terms of reference of a review into enhancing our legislative response to new psychoactive substances.
Statement on the presence of new psychoactive substances in custodial settings.
The Advisory Council on the Misuse of Drugs (ACMD) summarise their contribution to the impact review of the Psychoactive Substances Act 2016
The penalties if you are caught taking or dealing drugs - drug classification, fines and prison sentences
This review summarises the latest evidence and makes recommendations for secure mental health service commissioners and providers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.